Inducible nitric oxide synthase (iNOS) |
Reduced |
Relaxed tubal smooth muscle contractility and/or ciliary beat resulting in reduced tubal motility |
Interstitial cells of Cajal (ICC) |
Reduced |
Loss of pacemaker activity within the Fallopian tube resulting in reduced smooth muscle contractility |
Endocannabinoid receptor (CB1) |
Reduced |
Aberrant tubal smooth muscle contractility |
Prokineticin receptors (PROKRs) |
Reduced |
Aberrant tubal smooth muscle contractility |
Activated macrophages |
Increased |
Up-regulation of prostaglandins resulting in aberrant tubal smooth muscle contractility |
Interleukin-8 (IL-8) |
Increased |
Tubal tissue damage resulting from infection |
Mucin 1 (MUC1) |
Reduced |
Allows implantation of abnormal embryos |
Activins |
Increased |
Dysregulation of tissue remodelling allowing for tubal implantation |
Increased NOS production contributing to aberrant tubal motility |